Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Fever

NCT04907682 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER_GOV

Sponsor class

Conditions

Lassa Fever

Interventions

DRUG: Ribavirin iv
DRUG: Favipiravir

Sponsor

Bernhard Nocht Institute for Tropical Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]